Hot-Melt Pneumatic Extrusion-Based 3D-Printed Bilayer Tablets Enabling Sequential Release of Levocetirizine and Montelukast
Pharmaceutics · 03.04.2026 · 18 (4) · 444
DOI: 10.3390/pharmaceutics18040444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 03.04.2026. Verfasst von Ga-Ram Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biohealth Regulatory Science, Graduate School of Ajou University, Suwon 16499, Republic of Korea. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, the GRRC program of Gyeonggi province, the Ajou University research fund.
Abstract (Originalsprache)
Background/Objectives: This study aimed to develop bilayer tablets using hot-melt pneumatic extrusion (HMPE)-based 3D printing for the integrated treatment of allergic rhinitis and asthma. The formulation combined levocetirizine dihydrochloride (immediate release) and montelukast sodium (delayed release) within a single dosage form to provide a sequential-release formulation strategy relevant to the intended pharmacological roles of the two drugs. Distinct polymer matrices were selected for each drug layer to ensure mechanical robustness, stability, and appropriate release characteristics.
Methods
The printed tablets were systematically characterized by mechanical testing, differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and in vitro dissolution. Drug content uniformity was evaluated in accordance with USP .
Results
The tablets satisfied USP standards for content uniformity and exhibited sufficient mechanical strength for handling and packaging. DSC and PXRD analyses indicated amorphization of levocetirizine within the polymer matrix, while the amorphous state of the raw montelukast used in this study was retained after printing. In vitro dissolution tests demonstrated immediate release of levocetirizine in acidic medium (pH 1.2) and delayed release of montelukast at intestinal pH (6.8), thereby achieving the intended dual-phase release profile.
Conclusions
These findings demonstrate the feasibility of fabricating an HMPE-based 3D-printed bilayer tablet integrating immediate-release levocetirizine and delayed-release montelukast, with reproducible dual-phase release and drug-specific solid-state and performance characteristics within a single oral dosage form.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biohealth Regulatory Science, Graduate School of Ajou University, Suwon 16499, Republic of Korea.
- Department of Bioengineering, University of California, Berkeley, CA 94720, USA.
- Department of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
ORCID-Profile: Ga-Ram Kim, Hyo-Eon Jin
Förderung
- National Research Foundation of Korea
- the GRRC program of Gyeonggi province
- the Ajou University research fund
Zitieren
APA
Kim, G. R., Cho, J. Y., Lee, S. W., & Jin, H. E. (2026). Hot-Melt Pneumatic Extrusion-Based 3D-Printed Bilayer Tablets Enabling Sequential Release of Levocetirizine and Montelukast. Pharmaceutics, 18(4), 444. https://doi.org/10.3390/pharmaceutics18040444
Vancouver
Kim GR, Cho JY, Lee SW, Jin HE. Hot-Melt Pneumatic Extrusion-Based 3D-Printed Bilayer Tablets Enabling Sequential Release of Levocetirizine and Montelukast. Pharmaceutics. 2026;18(4):444. doi:10.3390/pharmaceutics18040444
BibTeX
@article{Kim2026,
author = {Kim, Ga-Ram and Cho, Ji-Young and Lee, Seung-Wuk and Jin, Hyo-Eon},
title = {Hot-Melt Pneumatic Extrusion-Based 3D-Printed Bilayer Tablets Enabling Sequential Release of Levocetirizine and Montelukast},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {4},
pages = {444},
doi = {10.3390/pharmaceutics18040444}
}
EUVIMED